Fennec Pharmaceuticals Inc. (FENC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fennec Pharmaceuticals In...

    NASDAQ: FENC · Real-Time Price · USD
    9.88
    0.21 (2.17%)
    At close: Oct 03, 2025, 3:59 PM
    9.88
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Fennec Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -70K -16.05M -23.71M -17.35M
    Depreciation & Amortization
    		 800K n/a 132K 14K
    Stock-Based Compensation
    		 5.06M 5.35M 4.22M 4.01M
    Other Working Capital
    		 16.13M 819.83K 1.61M -138K
    Other Non-Cash Items
    		 5.06M 326K 334K 307K
    Deferred Income Tax
    		 n/a n/a n/a -14K
    Change in Working Capital
    		 16.13M -6.78M 1.1M -932K
    Operating Cash Flow
    		 26.98M -17.14M -18.06M -14.22M
    Capital Expenditures
    		 n/a 2.75 n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a
    Debt Repayment
    		 -13M 5M 19.93M 5M
    Common Stock Repurchased
    		 n/a -78K -194K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -197.08K 1.64M 797K -22K
    Financial Cash Flow
    		 -13.62M 6.64M 20.73M 4.98M
    Net Cash Flow
    		 13.37M -10.51M 2.67M -9.24M
    Free Cash Flow
    		 26.98M -17.14M -18.06M -14.22M

    Add to Watchlist